Join the leading experts in interventional cardiology now!
Prof. Michael Haude,
The European Association of Percutaneous Cardiovacsular Interventions (EAPCI) has now more than 7 400 members from 133 countries. Since its foundation in 2006 EAPCI developed a very dynamic and productive structure driven by the leadership of highly dedicated individuals.
As a result of the 2016 elections, a new Board has been constituted by our members and it will be my privilege to lead the Association for the term May 2016 to May 2018 with the support of Andreas Baumbach as President-Elect, Stephan Windecker as Past-President, Bernard Chevalier as Treasurer, Giulio Guagliumi as Secretary , Patrick Serruys as Editor-in-Chief of EuroIntervention, and the two appointed PCR Board representatives Christoph Naber and Bernard Prendergast.
During the upcoming term 2016-2018, I will focus with the support of the Board and the different committees on the following objectives based on the EAPCI long-term strategy of established throughout the last years:
Interventional cardiovascular medicine has contributed immensely to improve patient outcome. As in previous years, the Association will further excel scientific knowledge and standards in several ways:
Transcatheter valve interventions with their recent most important advances have significantly contributed to the field of cardiovascular medicine. Most recently, the Valve for Life initiative has been established by EAPCI to broaden the use of this interventional technology according to recent guideline recommendations. This project has been started successfully in two pilot countries (Poland and France) and will help to facilitate adoption of this new technology across Europe, very similar to what has been achieved with primary PCI for STEMI in the Stent for Life initiative. In addition, the Association will continue to advance this subspecialty in numerous ways:
The prolific development in several domains including coronary interventions, transcatheter heart valve interventions, structural heart disease interventions, neurohumoral denervation and interventional pharmacology pose an increasing responsibility to provide a common ground of knowledge and expertise. The Association aims to further raise educational standards by
The Association has successfully established a dedicated EAPCI Women Committee that has already put lots of effort in the field of gender issues in interventional cardiology and will continue to do so in collaboration with several other EAPCI committees.
We continuously need to invest in the upcoming and future interventional cardiovascular community in order to attract the most talented individuals into our subspecialty. The Association has implemented the very active and productive Young Committee which will continue to develop specific initiatives such as CathGO adapted to the needs of young interventional cardiologists in training.
In the near future, and as all other ESC Associations, we will have to vote on a new EAPCI Constitution adapted to the ESC Statutes to ensure cohesion as a whole, facilitate internal ESC governance. In this broad context, a new inclusive membership programme with different membership levels will be established with different levels of benefits of high value to the interventional community.
Finally, in a more complicated environment of getting sponsorship, the EAPCI Executive Board will continuously put lots of effort into fund raising in order to actively proceed all of these projects.
Professor Michael HaudePresident of the European Association of PercutaneousCardiovascular Interventions (EAPCI) 2016-2018
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved